Skip to main content
OpenTrials

Clinical trial condition

Newly Diagnosed Multiple Myeloma

Explore clinical trials studying Newly Diagnosed Multiple Myeloma. Study availability and eligibility vary by location and protocol.

17 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Newly Diagnosed Multiple Myeloma trial results

Recruiting

NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide

NCT05558319

Conditions
Newly Diagnosed Multiple Myeloma
Locations
  • Hospital Principe de Asturias Alcalá de Henares, Madrid, Spain
  • Hospital Universitario Quirón Salud Madrid Pozuelo de Alarcón, Madrid, Spain
  • Clinica Universidad Navarra (CUN) Pamplona, Navarre, Spain
  • Hospital General Universitario de Albacete Albacete, Spain
View all 68 locations
View Trial Details
Recruiting

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

NCT06679101

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Beverly Hills, California, United States
  • GSK Investigational Site Pasadena, California, United States
View all 181 locations
View Trial Details
Recruiting

Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients

NCT05665140

Conditions
Newly Diagnosed Multiple Myeloma
Locations
  • Heloisklinikum Berlin Buch GmbH Berlin, Germany
  • Klinikum Bielefeld - Onkologie, Hämatologie, Paliativmedizin Bielefeld, Germany
  • Universitätsklinikum Hamburg Eppendorf (UKE) Hamburg, Germany
  • Universitätsklinikum Schleswig-Holstein, Campus Lübeck Lübeck, Germany
View Trial Details
Not Yet Recruiting

ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma

NCT07247097

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions